Flagship Harbor Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Flagship Harbor Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300	Closed	-$1.01K	–	1456
2025 Q4	$1.01K	Buy	+300	New	+$779	﹤0.01%	1937
2020 Q4	–	Sell	-300	Closed	-$2K	–	1117
2020 Q3	$2K	Hold	300	–	–	﹤0.01%	1729
2020 Q2	$3K	Hold	300	–	–	﹤0.01%	1722
2020 Q1	$3K	Hold	300	–	–	﹤0.01%	1546
2019 Q4	$4K	Hold	300	–	–	﹤0.01%	1572
2019 Q3	$2K	Hold	300	–	–	﹤0.01%	1678
2019 Q2	$3K	Sell	300 -58	-16%	-$650	﹤0.01%	1614
2019 Q1	$4K	Hold	358	–	–	﹤0.01%	1540
2018 Q4	$3K	Hold	358	–	–	﹤0.01%	1563
2018 Q3	$5K	Hold	358	–	–	﹤0.01%	1692
2018 Q2	$5K	Buy	+358	New	+$5.3K	﹤0.01%	1640

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Flagship Harbor Advisors's IRWD Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 300 shares — an estimated $1.01K sold.

Flagship Harbor Advisors first reported a position in IRWD in Q2 2018 and held it in 11 quarters. The position peaked at $5K in Q3 2018. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Flagship Harbor Advisors reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Flagship Harbor Advisors sold 300 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $1.01K.
Flagship Harbor Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2018 and held it in 11 quarters.
Flagship Harbor Advisors's Ironwood Pharmaceuticals position peaked at $5K in Q3 2018.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.